Head-to-head · WeighScore
Enhance MD vs Oria Meds
The verdict
Enhance MD takes it — 84.8/100 to 63.6/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Enhance MD | Oria Meds |
|---|---|---|
| WeighScore | 84.8/100 | 63.6/100 |
| Grade | B | C |
| Site position | #5 | #283 |
| Semaglutide | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay | $199/mo (first month $89; the three- and six-month plans both cost $209 a month) |
| Tirzepatide | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay | $369/mo (first month $129; three months $316/mo, six months $299/mo) |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #5 · B
Strengths
- Transparent tiered pricing across sema, tirz, microdose, and combo
- Dose-flat — the price does not step up as you titrate
- Six-month lab testing plus provider-led care
- NAD+ longevity adjacency available
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- No oral or sublingual route
- States served are not published
- Higher entry price than the cheapest compounded programs
Site position #283 · C
Strengths
- Names its dispensing pharmacy, PerfectRx, with a street address and a phone number
- Free shipping and interest-free installments are offered at checkout
- The intake's plan menu returned identical ladders in two different states, so the price is not being varied by geography in the states tested
- Coverage is stated as all 50 states, subject to provider availability
Where it loses points
- Neither semaglutide nor tirzepatide is named anywhere on the public site; the molecule first appears at step two of the intake, after name, email, phone and shipping address are collected
- The homepage sells “starting at $149” and “starting at $249” and neither figure appears in the intake in either state tested
- The semaglutide ladder is inverted: one month is $199 a month, three months and six months are both $209 a month
- $89 and $129 are first-month promotional rates; the standing rates are $199 and $369
- A second price table sits in the homepage script and renders nowhere, quoting a $329 tirzepatide figure the live intake contradicts
- Two different scarcity counters appear on consecutive checkout screens, and review turnaround is stated as 24 hours in one place and 48 in another
- No legal entity, state of organization or governing law is published, and no clinician or NPI is named
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.